Hangzhou Alltest Biotech Co., Ltd. (688606.SS)
CNY 67.4
(0.06%)
CNY 67.4
(0.06%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.11 Billion CNY | -12.42% |
| 2022 | 4.69 Billion CNY | 17.25% |
| 2021 | 4 Billion CNY | 248.22% |
| 2020 | 1.15 Billion CNY | 246.19% |
| 2019 | 332.5 Million CNY | 30.62% |
| 2018 | 254.56 Million CNY | 33.57% |
| 2017 | 190.57 Million CNY | 219.06% |
| 2016 | 59.73 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 4.16 Billion CNY | -0.35% |
| 2024 Q1 | 4.14 Billion CNY | 0.6% |
| 2024 Q2 | 4.17 Billion CNY | 0.93% |
| 2023 Q3 | 4.04 Billion CNY | 0.38% |
| 2023 FY | 4.11 Billion CNY | -12.42% |
| 2023 Q4 | 4.11 Billion CNY | 1.74% |
| 2023 Q2 | 4.03 Billion CNY | -11.78% |
| 2023 Q1 | 4.56 Billion CNY | -2.8% |
| 2022 FY | 4.69 Billion CNY | 17.25% |
| 2022 Q3 | 4.7 Billion CNY | -2.57% |
| 2022 Q4 | 4.69 Billion CNY | -0.15% |
| 2022 Q2 | 4.83 Billion CNY | -5.43% |
| 2022 Q1 | 5.1 Billion CNY | 27.44% |
| 2021 Q2 | 3 Billion CNY | -0.13% |
| 2021 FY | 4 Billion CNY | 248.22% |
| 2021 Q1 | 3.01 Billion CNY | 161.77% |
| 2021 Q4 | 4 Billion CNY | 24.72% |
| 2021 Q3 | 3.21 Billion CNY | 6.8% |
| 2020 Q3 | 732.15 Million CNY | -2.42% |
| 2020 Q2 | 750.28 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 1.15 Billion CNY | 246.19% |
| 2020 Q4 | 1.15 Billion CNY | 57.22% |
| 2019 Q4 | 332.5 Million CNY | 0.0% |
| 2019 FY | 332.5 Million CNY | 30.62% |
| 2018 FY | 254.56 Million CNY | 33.57% |
| 2017 FY | 190.57 Million CNY | 219.06% |
| 2016 FY | 59.73 Million CNY | 0.0% |